Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | 62 | 01.06.15 | |
Michael Kaleko
CTO | Chief Tech/Sci/R&D Officer | - | 01.03.12 |
- | - | ||
T. J. Swope
SEC | Corporate Secretary | - | - |
Manel Cascalló
PRN | Corporate Officer/Principal | - | 23.03.22 |
Vince Wacher
PRN | Corporate Officer/Principal | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Jeff Wolf
BRD | Director/Board Member | 60 | 01.01.06 |
John Monahan
BRD | Director/Board Member | 77 | 11.11.20 |
Jeffrey Kraws
CHM | Chairman | 59 | 01.01.06 |
Chief Executive Officer | 62 | 01.06.15 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 17 868 282 | 16 816 750 ( 94,12 %) | 720 233 ( 4,031 %) | 94,12 % |
Unternehmenskontakt
Theriva Biologics, Inc.
9605 Medical Center Drive Suite 270
20850, Rockville
+301 417 4364
http://www.therivabio.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+3.91% | 109 Mrd. | |
+10.87% | 105 Mrd. | |
+1.28% | 22.25 Mrd. | |
-13.14% | 22.09 Mrd. | |
-7.05% | 18.68 Mrd. | |
-38.36% | 17.58 Mrd. | |
-10.66% | 16.85 Mrd. | |
+3.75% | 13.76 Mrd. | |
+36.70% | 12.46 Mrd. |